submit news    HOME | FEEDBACK  


« NAVIGATION »
NEWS

- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials

- MEMS

- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software
COMPANIES
EVENTS

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events
FEEDBACK
ADVERTISE
LINK TO US

« PARTNERS »
Become A Nanotechwire Partner

FEI Company

Veeco Instruments

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here
« NEWSLETTER »



« SEARCH »







12/14/2004 10:17:04 PM
Nanomix and UCLA Sign Exclusive Licensing Agreement

Nanomix Inc., a leading nanotechnology company, today announced that it has signed an exclusive licensing agreement with The Regents of the University of California, Los Angeles, for technology used to detect biomolecules such as DNA and proteins. The licensing agreement gives Nanomix the right to use and further develop the technology, invented by Dr. George Gruner of UCLA. Future applications of this promising technology may range from glucose monitoring to viral and infectious disease detection and even homeland security.

"We are very excited to be licensing partners with UCLA, helping to advance our biomolecule detection platform," said David Macdonald, CEO and President of Nanomix. "Dr. Gruner's discoveries will be used to develop products including a range of sensors and detectors for medical, diagnostic, industrial and forensic uses. These sensors will permit the direct electronic detection and identification of biomolecules, resulting in faster, simpler and cheaper measurements."

"Electronic detection of biomolecules, the subject of the licensed invention will likely play a significant role in a variety of products in the biomedical and biotechnology arena, ranging from early detection of cancer to gene chips," said Dr. George Gruner. "I anticipate that Nanomix will pursue a vigorous research and development program that will move the invention from the early-stage feasibility study to a product development phase."

The license includes a pending patent application by Dr. Gruner (Publication No.: US 2004-0067,530), describing nano-structured electronic devices which include biological probe molecules. The probe molecules produce a measurable electrical effect when binding or interacting with a target biological molecule.

Other Headlines from Nanomix ...
 - Nanomix Receives Seventh U.S. Patent in Hydrogen Energy Storage
 - Nanomix Announces New Patent; Broad Claims Granted for Arrayed Nanostructured Detection Devices
 - Nanomix Announces Increase in Grant From Department of Homeland Security to $1.26 Million
 - Nanomix Announces Award of $500K National Science Foundation Phase IIB Grant
 - Nanomix and UC Berkeley Announce E-Nose Detection Collaboration

Other Headlines from University Of California, Los Angeles ...
 - Scientists engineer nanoscale vaults to encapsulate 'nanodisks' for drug delivery
 - Optical microscope without lenses produces high-resolution 3-D images on a chip
 - UCLA researchers now one step closer to controlled engineering of nanocatalysts
 - Study develops new approaches for sorting out complexities of cancer cells
 - Graphene study - Is space like a chessboard?

More Bio/Medicine Headlines ...
 - Experiments Settle Long-Standing Debate about Mysterious Array Formations in Nanofilms
 - "Critical baby step" taken for spying life on a molecular scale
 - Researchers create nanopatch for the heart
 - Seeing an atomic thickness
 - First-ever sub-nanoscale snapshots of renegade protein in Huntington's Disease


« Back To List »

« GET LISTED »
- submit company
- submit news
- submit events
- advertise here

« EVENTS »
- More Events


Copyright 2014 Nanotechwire.com | Privacy Policy |